BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 18995998)

  • 1. [Childhood medulloblastoma].
    Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
    Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
    Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
    Packer RJ
    Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
    Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
    Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of radiation treatment planning and patient fixation on the results of postoperative radiotherapy of childhood medulloblastoma.
    Kocsis B; Székely G; Pap L; Németh G
    Strahlenther Onkol; 2003 Dec; 179(12):854-9. PubMed ID: 14652675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of radiation in children with medulloblastoma/PNET.
    Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
    Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult medulloblastoma: an analysis of survival and prognostic factors.
    Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
    Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a prospective study on the treatment of medulloblastoma in adults.
    Brandes AA; Franceschi E; Tosoni A; Blatt V; Ermani M
    Cancer; 2007 Nov; 110(9):2035-41. PubMed ID: 17823910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP).
    Rivera-Luna R; López E; Rivera-Marquez H; Rivera-Ortegón F; Altamirano-Alvarez E; Mercado G; Covarrubias G; Rueda-Franco F; Marhx-Bracho A; Gutiérrez P
    Childs Nerv Syst; 2002 Feb; 18(1-2):38-42. PubMed ID: 11935242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
    Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
    J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiotherapy of cerebellar medulloblastoma in children].
    Shcherbenko OI; Zelinskaia NI; Parkhomenko RA; Ardatova GV; Hechaeva VN
    Vopr Onkol; 1999; 45(1):95-7. PubMed ID: 10941376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.
    Padovani L; Sunyach MP; Perol D; Mercier C; Alapetite C; Haie-Meder C; Hoffstetter S; Muracciole X; Kerr C; Wagner JP; Lagrange JL; Maire JP; Cowen D; Frappaz D; Carrie C
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):433-40. PubMed ID: 17498567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Craniospinal radiotherapy in adult medulloblastoma.
    Selek U; Zorlu F; Hurmuz P; Cengiz M; Turker A; Soylemezoglu F; Gurkaynak M
    Strahlenther Onkol; 2007 May; 183(5):236-40. PubMed ID: 17497094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.